Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Field Value
Model ID13-065-01
Model NameWang 2013
Pubmed ID23485798
First AuthorWang
JournalCardiology
Year2013
TitleDevelopment and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Primary Index ConditionCoronary Artery Disease (CAD)
Secondary Index ConditionAcute Coronary Syndrome (ACS)
OutcomeNo Reflow
Model Sample Size1615
Cohort Sample Size1615
Number of Events343
Follow-Up DurationShort (<3 months)
AUROC0.757
Calibration Reported
CovariatesAge >=55 years, Age <55 years, Plasma glucose on admission >=12.0 mmol/l, Plasma glucose on admission <12.0 mmol/l, Neutrophil count >=8.81 x 10^9/l, Neutrophil count <8.81 x 10^9/l, Killip class 4, Killip class <4, Administration of beta blocker: yes, Ad
Mesh TermsTo be updated
Number of Validations1

External Validations

Yes
1
0.757
1st Author Year Sample Size AUC Calibration Relatedness
Wang 2013 692 0.757 Yes Closely Related